Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IRAK4 | Q9NWZ3 | 11/20 | 0.42 |
| ▸ | CHRNB4 | P30926 | 4/20 | 0.37 |
| ▸ | CHRNA3 | P32297 | 4/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20531358 | 1.00 | IRAK4 (0.42) | IRAK4CHRNB4CHRNA3MEN1KMT2A | |
| SCHEMBL28663618 | 0.89 | F2RL3 (0.38) | IRAK4CHRNB4CHRNA3MEN1KMT2A | |
| SCHEMBL28663614 | 0.89 | F2RL3 (0.38) | IRAK4CHRNB4CHRNA3MEN1KMT2A | |
| SCHEMBL20531370 | 0.85 | IRAK4 (0.44) | IRAK4L3MBTL1 | |
| SCHEMBL20531369 | 0.85 | IRAK4 (0.44) | IRAK4L3MBTL1 | |
| SCHEMBL19030657 | 0.74 | IRAK4 (0.38) | IRAK4MEN1KMT2AL3MBTL1 | |
| SCHEMBL19030656 | 0.74 | IRAK4 (0.38) | IRAK4MEN1KMT2AL3MBTL1 | |
| SCHEMBL19046026 | 0.73 | ALOX5AP (0.41) | IRAK4 | |
| SCHEMBL28670059 | 0.73 | ALOX5AP (0.41) | IRAK4 | |
| SCHEMBL29935102 | 0.73 | ALOX5AP (0.41) | IRAK4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10988478-B1 | Pyrazolo[1,5a]pyrimidine derivatives as IRAK4 modulators | GENENTECH, INC. (US) | 2021-04-27 | — | — | US | disclosed |
| US-20180298015-A1 | PYRAZOLO[1,5a]PYRIMIDINE DERIVATIVES AS IRAK4 MODULATORS | GENENTECH, INC. (US) | 2018-10-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180298015-A1 | PYRAZOLO[1,5a]PYRIMIDINE DERIVATIVES AS IRAK4 MODULATORS | IRAK1, IRAK4, IRAK2 | IRAK4 2/4885CHRNB4 3227/4885CHRNA3 3501/4885 |
| US-10988478-B1 | Pyrazolo[1,5a]pyrimidine derivatives as IRAK4 modulators | IRAK1, IRAK4, IRAK2 | IRAK4 2/4885CHRNB4 3227/4885CHRNA3 3501/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.